| Prev Close | 30.35 |
| Day Low/High | 28.50 / 30.50 |
| 52 Wk Low/High | 9.72 / 30.95 |
Aurinia Pharmaceuticals Inc. (AUPH)
29.92
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 128.40B |
| Market Cap | 3.90B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
I Have 14 Key Stocks on My Shopping List
My positions change very fast and I'm actively trading all these names.
10 Good-Looking Small-Cap Stocks as Markets Mildly Correct
The process of closing the gap between large-caps and secondary stocks may be starting today.
Here's How I'd React to a Selloff on Jackson Hole
The move on Thursday wasn't as much a surprise as it would seem, but now we must look to what could happen next.
Lethargic Indices Mask a Spark in Smaller Gaming Stocks
A number of gambling stocks are up on word that DraftKings plans to buy Golden Nugget Online Gaming.
Aurinia Pharmaceuticals' Charts Are Showing Side Effects
Here's what to avoid.
I'm Looking for Some Mild Pullbacks to Create Another Round of Setups
There are plenty of small-caps that have finally bounced and are now consolidating.
The Indices and Broader Markets Need Much More Work to Hit a Good Low
Much of the action has to do with the disconnect recently between the indices and the vast majority of individual stocks.
The Good News Is That the Overall Price Action Is Positive
We're going to see some random action in front of the weekend.
It's Time for a Bit of Repositioning as Another Earnings Season Approaches
The end of the quarter means a new round of quarterly reports is near, so it pays to keep an eye on favorite names.
The Market Turns on News of Delta Variant, Russell Indexing
Technology strengthens, while the Dow Jones industrial average and Russell 2000 lag.
Stock Picking Remains the Name of the Game
The tricky part is that sector strength is shifting fast.
It Is a Dull Market, but Here Are Several Names I'm Trading
Action like this sometimes leads to a 'don't short a dull market' response.
My Impression Now Is That Market Players Lack Energy
I don't want to sound negative as it's a major positive that there isn't aggressive downside follow through.
Focus on the Price Action, and Avoid the Perma-Pessimists
Stocks with good charts, good fundamentals, and good stories are attracting buyers.
This Picker's on the Prowl: Here's What I'm Trading
I've been very busy making some quick trades.
Keep an Eye on Biotech and Cryptos as the Weekend Approaches
There's one name I've added to today.
Long-Suffering Biotech May Be Hitting a Bottom
Here are some biotech and gaming names I am watching as these sectors begin to rotate.
Biotechs Are One of the Few Positives in This Ugly Market
Of 56 recent ARKK buys, only two are trading in positive territory Wednesday.
The Selling Pressure on Many Stocks Is Brutal
The good news is that this sort of action always eventually leads to great stock picking.
It's a Strange Mix of Action Out There
The best momentum on my screens right now are the U.S. cannabis plays that are referred to as Multi-State Operators.
Pockets of Momentum Remain Very Narrow
There continues to be little energy among stock pickers.
My Game Plan as We Wait for Small-Caps to Follow Through
It is premature to declare the rotation back into small-cap stocks is dead.
Small-Caps Are Finally Showing Some Relative Strength
I'm feeling better about more aggressive stock picking, but I'm staying selective.
The Art of the Remount
Rebuying a stock that you have previously sold can be an extremely powerful trading strategy.
The Markets Are Steadily Climbing
I'm hoping that we see some more rotational action rather than a broad market correction.
How to Bottom Fish
Here's my three-point guide -- with a focus on the biotechs.
Making the Best of the Peculiar Market Action
Trading in biotech stocks and a particular SPAC play are on my mind.
16 Biotechs I Like Even as a Lack of Liquidity Is Hurting the Market
Quite a few stocks are fading right now -- not due to poor fundamentals, but due to lack of buying interest.
